Breynn Entwistle
Epilepsy · Marlboro, NJNPI 1003302183
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 285 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 31 manufacturers reported payments, led by UCB, Inc. at 25.4% of the total.
Across 285 payments — averaging $14.82 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- UCB, Inc.$1K
- AbbVie$638
- Neurelis, Inc.$441
- SK Life Science, Inc.$428
- Lilly USA, LLC$275
- Teva Pharmaceuticals USA, Inc.$145
- plus $1K from 25 others
What the payments were for
- Food & beverage$4,225100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| UCB, Inc. | 74 | $1,072 |
| AbbVie | 48 | $638 |
| Neurelis, Inc. | 34 | $441 |
| SK Life Science, Inc. | 26 | $428 |
| Lilly USA, LLC | 18 | $275 |
| Teva Pharmaceuticals USA, Inc. | 10 | $145 |
| Pfizer | 8 | $133 |
| Impel Pharmaceuticals Inc. | 8 | $126 |
| Aucta Pharmaceuticals, Inc. | 9 | $126 |
| Jazz Pharmaceuticals Inc. | 6 | $102 |
| Aquestive Therapeutics, Inc. | 7 | $99 |
| Otter Pharmaceuticals, LLC | 5 | $89 |
| Lundbeck LLC | 4 | $66 |
| Livanova USA, Inc. | 2 | $59 |
| Biohaven Pharmaceutical Holding Company Ltd. | 4 | $57 |
| Sumitomo Pharma America, Inc. | 3 | $57 |
| Biomarin Pharmaceutical Inc. | 2 | $45 |
| Otsuka America Pharmaceutical, Inc. | 2 | $40 |
| Immedica Pharma US, Inc. | 2 | $32 |
| Eisai Inc. | 2 | $31 |
| AstraZeneca | 1 | $20 |
| Axsome Therapeutics, Inc. | 1 | $18 |
| Neos Therapeutics, LP | 1 | $17 |
| Amgen | 1 | $16 |
| Novocure Inc. | 1 | $16 |
| Azurity Pharmaceuticals, Inc. | 1 | $15 |
| Collegium Pharmaceutical, Inc. | 1 | $14 |
| Biocodex, Inc. | 1 | $14 |
| Medtronic | 1 | $13 |
| Boston Scientific | 1 | $12 |
| Bio Products Laboratory USA, Inc. | 1 | $9 |
How this compares
Too few epilepsy providers in New Jerseyto place this figure against a meaningful peer group, so we don't.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| XcopriCenobamate | 91 | $176,630 |
| BriviactBrivaracetam | 42 | $73,077 |
| Rufinamide | 13 | $31,583 |
| AptiomEslicarbazepine Acetate | 13 | $30,333 |
| VimpatLacosamide | 17 | $30,063 |
| Lamotrigine ErLamotrigine | 39 | $16,378 |
| Nurtec OdtRimegepant Sulfate | 13 | $15,787 |
| NayzilamMidazolam | 11 | $15,235 |
| Lacosamide | 64 | $7,660 |
| Levetiracetam ErLevetiracetam | 81 | $7,220 |
| Levetiracetam | 96 | $6,941 |
| Lamotrigine | 126 | $3,035 |
| Clobazam | 24 | $2,787 |
| Donepezil Hcl | 70 | $2,700 |
| Tegretol XrCarbamazepine | 11 | $2,682 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| SK Life Science, Inc.Xcopri | $428 | $176,63091 claims |
| UCB, Inc.Briviact, Vimpat, Nayzilam | $1,072 | $118,37570 claims |
| PfizerNurtec Odt | $133 | $15,78713 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. There are too few epilepsy providers in New Jerseyon file to place this against a meaningful peer group, so we don't.
Other epilepsy in Marlboro
- Aissa AlexeevaLawrenceville$3K
- Manuel VergaraLawrenceville$3K
- Nicole HartmannLawrenceville$3K
- Olga AlexeevaMorristown$2K
- Alma YumSummit$2K
- Kimberly PalangioLawrenceville$2K
- Palak PatelEdison$1K
- Stephen WongSummit$871
- Stefan GillenPompton Plains$871
- Helen HanNew Brunswick$52
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.